Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan
With
University of Nebraska
Mayo Clinic
National Eye Institute (NEI)
Age
40–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Either gender.
Any self-declared ethnoracial category.
Greater than or equal to 40 years.
Healthy eyes with the crystalline lens, without glaucoma (cup:disc ratio \< 0.8 both eyes; asymmetry of cup:disc ratio between eyes \< 0.2).
Open angles.
Ability to cooperate for aqueous humor dynamic studies.
You may not be if
Contact lenses removed prior to topical fluorescein instillation, and not used until the end of each fluorophotometry session.
Able to participate on site over the multi-visit study period.
Women who are pregnant due to IOP changes.
Any form of glaucoma, including extremely narrow angle with complete or partial closure.
Current use of any glaucoma medication, either topically or orally.
Chronic or recurrent inflammatory eye disease.
Ocular trauma within the past 6 months.
Ocular infection or ocular inflammation in the past 3 months.
Clinically significant retinal disease.
Any abnormality preventing reliable fluorophotometry of either eye, such as corneal scarring or severe dry eye that results in punctate fluorescein staining of the cornea.
Intraocular surgery within 6 months.
Serious hypersensitivity to any components of the study medications or risk from treatment with glaucoma medications, such as severe asthma or emphysema.
Subjects must be on a stable regimen for at least 30 days prior to the Visit 1 regarding a chronic systemic medication that may affect IOP (i.e., sympathomimetic agents, beta-blockers, alpha-adrenergic agonists, alpha-adrenergic blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, etc.). Any change of such medication during the study period will result in exclusion.
Use of any glucocorticoid by any route. Subject must be washed out of the glucocorticoid for at least 2 weeks before study entry.
